Table of Contents Chapter 1 Overview of Spiromesifen (CAS 283594-90-1) 1.1 Definition of Spiromesifen (CAS 283594-90-1) in This Report 1.2 Commercial Types of Spiromesifen (CAS 283594-90-1) 1.2.1 Powder 1.2.2 Solution 1.3 Downstream Application of Spiromesifen (CAS 283594-90-1) 1.3.1 Agriculture 1.3.2 Chemical Industry 1.3.3 Others 1.4 Development History of Spiromesifen (CAS 283594-90-1) 1.5 Market Status and Trend of Spiromesifen (CAS 283594-90-1) 2013-2023 1.5.1 North America Spiromesifen (CAS 283594-90-1) Market Status and Trend 2013-2023 1.5.2 Regional Spiromesifen (CAS 283594-90-1) Market Status and Trend 2013-2023 Chapter 2 North America Market Status and Forecast by Regions 2.1 Market Status of Spiromesifen (CAS 283594-90-1) in North America 2013-2017 2.2 Consumption Market of Spiromesifen (CAS 283594-90-1) in North America by Regions 2.2.1 Consumption Volume of Spiromesifen (CAS 283594-90-1) in North America by Regions 2.2.2 Revenue of Spiromesifen (CAS 283594-90-1) in North America by Regions 2.3 Market Analysis of Spiromesifen (CAS 283594-90-1) in North America by Regions 2.3.1 Market Analysis of Spiromesifen (CAS 283594-90-1) in United States 2013-2017 2.3.2 Market Analysis of Spiromesifen (CAS 283594-90-1) in Canada 2013-2017 2.3.3 Market Analysis of Spiromesifen (CAS 283594-90-1) in Mexico 2013-2017 2.4 Market Development Forecast of Spiromesifen (CAS 283594-90-1) in North America 2018-2023 2.4.1 Market Development Forecast of Spiromesifen (CAS 283594-90-1) in North America 2018-2023 2.4.2 Market Development Forecast of Spiromesifen (CAS 283594-90-1) by Regions 2018-2023 Chapter 3 North America Market Status and Forecast by Types 3.1 Whole North America Market Status by Types 3.1.1 Consumption Volume of Spiromesifen (CAS 283594-90-1) in North America by Types 3.1.2 Revenue of Spiromesifen (CAS 283594-90-1) in North America by Types 3.2 North America Market Status by Types in Major Countries 3.2.1 Market Status by Types in United States 3.2.2 Market Status by Types in Canada 3.2.3 Market Status by Types in Mexico 3.3 Market Forecast of Spiromesifen (CAS 283594-90-1) in North America by Types Chapter 4 North America Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Spiromesifen (CAS 283594-90-1) in North America by Downstream Industry 4.2 Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in Major Countries 4.2.1 Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in United States 4.2.2 Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in Canada 4.2.3 Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in Mexico 4.3 Market Forecast of Spiromesifen (CAS 283594-90-1) in North America by Downstream Industry Chapter 5 Market Driving Factor Analysis of Spiromesifen (CAS 283594-90-1) 5.1 North America Economy Situation and Trend Overview 5.2 Spiromesifen (CAS 283594-90-1) Downstream Industry Situation and Trend Overview Chapter 6 Spiromesifen (CAS 283594-90-1) Market Competition Status by Major Players in North America 6.1 Sales Volume of Spiromesifen (CAS 283594-90-1) in North America by Major Players 6.2 Revenue of Spiromesifen (CAS 283594-90-1) in North America by Major Players 6.3 Basic Information of Spiromesifen (CAS 283594-90-1) by Major Players 6.3.1 Headquarters Location and Established Time of Spiromesifen (CAS 283594-90-1) Major Players 6.3.2 Employees and Revenue Level of Spiromesifen (CAS 283594-90-1) Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Spiromesifen (CAS 283594-90-1) Major Manufacturers Introduction and Market Data 7.1 Bayer CropScience 7.1.1 Company profile 7.1.2 Representative Spiromesifen (CAS 283594-90-1) Product 7.1.3 Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Bayer CropScience 7.2 Fertiagro Pte 7.2.1 Company profile 7.2.2 Representative Spiromesifen (CAS 283594-90-1) Product 7.2.3 Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Fertiagro Pte 7.3 LGC Standards 7.3.1 Company profile 7.3.2 Representative Spiromesifen (CAS 283594-90-1) Product 7.3.3 Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of LGC Standards 7.4 Alta Scientific 7.4.1 Company profile 7.4.2 Representative Spiromesifen (CAS 283594-90-1) Product 7.4.3 Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Alta Scientific 7.5 Xinyi Huili Fine Chemical 7.5.1 Company profile 7.5.2 Representative Spiromesifen (CAS 283594-90-1) Product 7.5.3 Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Xinyi Huili Fine Chemical 7.6 Beijing Hecheng Pioneer Pharmaceutical Technology 7.6.1 Company profile 7.6.2 Representative Spiromesifen (CAS 283594-90-1) Product 7.6.3 Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Beijing Hecheng Pioneer Pharmaceutical Technology Chapter 8 Upstream and Downstream Market Analysis of Spiromesifen (CAS 283594-90-1) 8.1 Industry Chain of Spiromesifen (CAS 283594-90-1) 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Spiromesifen (CAS 283594-90-1) 9.1 Cost Structure Analysis of Spiromesifen (CAS 283594-90-1) 9.2 Raw Materials Cost Analysis of Spiromesifen (CAS 283594-90-1) 9.3 Labor Cost Analysis of Spiromesifen (CAS 283594-90-1) 9.4 Manufacturing Expenses Analysis of Spiromesifen (CAS 283594-90-1) Chapter 10 Marketing Status Analysis of Spiromesifen (CAS 283594-90-1) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Powder Table Advantage and Disadvantage of Solution Table Consumption Volume of Spiromesifen (CAS 283594-90-1) in North America by Regions 2013-2017 Table Revenue of Spiromesifen (CAS 283594-90-1) in North America by Regions 2013-2017 Table Consumption Volume of Spiromesifen (CAS 283594-90-1) in North America by Regions 2018-2023 Table Revenue of Spiromesifen (CAS 283594-90-1) in North America by Regions 2018-2023 Table Consumption Volume of Spiromesifen (CAS 283594-90-1) in North America by Types 2013-2017 Table Revenue of Spiromesifen (CAS 283594-90-1) in North America by Types 2013-2017 Table Consumption Volume of Spiromesifen (CAS 283594-90-1) by Types in United States 2013-2017 Table Consumption Volume of Spiromesifen (CAS 283594-90-1) by Types in Canada 2013-2017 Table Consumption Volume of Spiromesifen (CAS 283594-90-1) by Types in Mexico 2013-2017 Table Consumption Volume Forecast of Spiromesifen (CAS 283594-90-1) in North America by Types 2018-2023 Table Revenue Forecast of Spiromesifen (CAS 283594-90-1) in North America by Types 2018-2023 Table Demand Volume of Spiromesifen (CAS 283594-90-1) in North America by Downstream Industry 2013-2017 Table Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in United States 2013-2017 Table Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in Canada 2013-2017 Table Demand Volume of Spiromesifen (CAS 283594-90-1) by Downstream Industry in Mexico 2013-2017 Table Demand Volume Forecast of Spiromesifen (CAS 283594-90-1) in North America by Downstream Industry 2018-2023 Table Sales Volume of Spiromesifen (CAS 283594-90-1) in North America by Major Players 2013-2017 Table Revenue of Spiromesifen (CAS 283594-90-1) in North America by Major Players 2013-2017 Table Headquarters Location and Established Time of Spiromesifen (CAS 283594-90-1) Major Players Table Employees and Revenue Level of Spiromesifen (CAS 283594-90-1) Major Players Table Representative Spiromesifen (CAS 283594-90-1) Product One of Bayer CropScience Table Representative Spiromesifen (CAS 283594-90-1) Product Two of Bayer CropScience Table Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Bayer CropScience 2013-2017 Table Representative Spiromesifen (CAS 283594-90-1) Product One of Fertiagro Pte Table Representative Spiromesifen (CAS 283594-90-1) Product Two of Fertiagro Pte Table Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Fertiagro Pte 2013-2017 Table Representative Spiromesifen (CAS 283594-90-1) Product One of LGC Standards Table Representative Spiromesifen (CAS 283594-90-1) Product Two of LGC Standards Table Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of LGC Standards 2013-2017 Table Representative Spiromesifen (CAS 283594-90-1) Product One of Alta Scientific Table Representative Spiromesifen (CAS 283594-90-1) Product Two of Alta Scientific Table Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Alta Scientific 2013-2017 Table Representative Spiromesifen (CAS 283594-90-1) Product One of Xinyi Huili Fine Chemical Table Representative Spiromesifen (CAS 283594-90-1) Product Two of Xinyi Huili Fine Chemical Table Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Xinyi Huili Fine Chemical 2013-2017 Table Representative Spiromesifen (CAS 283594-90-1) Product One of Beijing Hecheng Pioneer Pharmaceutical Technology Table Representative Spiromesifen (CAS 283594-90-1) Product Two of Beijing Hecheng Pioneer Pharmaceutical Technology Table Spiromesifen (CAS 283594-90-1) Sales, Revenue, Price and Gross Margin of Beijing Hecheng Pioneer Pharmaceutical Technology 2013-2017